These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 9005911

  • 1. Short term prophylaxis against heterotopic bone after cementless hip replacement.
    Wurnig C, Auersperg V, Boehler N, Steindl M, Kiss H, Zweymuller K, Kotz R.
    Clin Orthop Relat Res; 1997 Jan; (334):175-83. PubMed ID: 9005911
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Indomethacin in the prevention of para-articular ossification following total hip endoprosthesis].
    Hochheim B, Wünsche F.
    Beitr Orthop Traumatol; 1990 Jun; 37(6):330-4. PubMed ID: 2117436
    [Abstract] [Full Text] [Related]

  • 4. [Postoperative radiotherapy in the prevention of heterotopic ossification after endoprosthetic hip joint replacement].
    Heyd R, Strassmann G, Kirchner J, Schopohl B, Böttcher HD.
    Strahlenther Onkol; 1996 Oct; 172(10):543-52. PubMed ID: 8966671
    [Abstract] [Full Text] [Related]

  • 5. Heterotopic bone formation in total hip arthroplasty: predisposing factors, classification and the significance for clinical outcome.
    Schara K, Herman S.
    Acta Chir Orthop Traumatol Cech; 2001 Oct; 68(2):105-8. PubMed ID: 11706718
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Naproxen for 8 days can prevent heterotopic ossification after hip arthroplasty.
    Gebuhr P, Wilbek H, Soelberg M.
    Clin Orthop Relat Res; 1995 May; (314):166-9. PubMed ID: 7634631
    [Abstract] [Full Text] [Related]

  • 8. [Prevention of heterotopic ossification following cementless hip replacement using 5 x 2 Gy fractionated irradiation. A prospective study].
    Sell S, Jany R, Kremling E, Esenwein S, Gaissmaier C, Küsswetter W.
    Z Orthop Ihre Grenzgeb; 1996 May; 134(4):375-80. PubMed ID: 8928569
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
    Liu HP, Li YJ, Wang CX, Li SH, Zhao ZW, Wang JH.
    Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
    [Abstract] [Full Text] [Related]

  • 11. Single dose 6 Gy prophylaxis for heterotopic ossification after total hip arthroplasty.
    Fingeroth RJ, Ahmed AQ.
    Clin Orthop Relat Res; 1995 Aug; (317):131-40. PubMed ID: 7671467
    [Abstract] [Full Text] [Related]

  • 12. Selective COX-2 inhibitor versus indomethacin for the prevention of heterotopic ossification after hip replacement: a double-blind randomized trial of 100 patients with 1-year follow-up.
    Grohs JG, Schmidt M, Wanivenhaus A.
    Acta Orthop; 2007 Feb; 78(1):95-8. PubMed ID: 17453399
    [Abstract] [Full Text] [Related]

  • 13. The influence of heterotopic ossification on functional status of hip joint following total hip arthroplasty.
    Pohl F, Seufert J, Tauscher A, Lehmann H, Springorum HW, Flentje M, Koelbl O.
    Strahlenther Onkol; 2005 Aug; 181(8):529-33. PubMed ID: 16044221
    [Abstract] [Full Text] [Related]

  • 14. Stable bony integration with and without short-term indomethacin prophylaxis. A 5-year follow-up.
    Trnka HJ, Zenz P, Zembsch A, Easley M, Ritschl P, Salzer M.
    Arch Orthop Trauma Surg; 1999 Aug; 119(7-8):456-60. PubMed ID: 10613239
    [Abstract] [Full Text] [Related]

  • 15. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
    Kjaersgaard-Andersen P, Schmidt SA.
    Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
    [Abstract] [Full Text] [Related]

  • 16. Heterotopic ossification prophylaxis following operative treatment of acetabular fracture.
    Johnson EE, Kay RM, Dorey FJ.
    Clin Orthop Relat Res; 1994 Aug; (305):88-95. PubMed ID: 8050251
    [Abstract] [Full Text] [Related]

  • 17. [Prevention of heterotopic ossification after THA with indomethacin: analysis of risk factors].
    Zehetgruber H, Grübl A, Goll A, Schwameis E, Wurnig C, Giurea A.
    Z Orthop Ihre Grenzgeb; 2005 Aug; 143(6):631-7. PubMed ID: 16380894
    [Abstract] [Full Text] [Related]

  • 18. Rofecoxib inhibits heterotopic ossification after total hip arthroplasty.
    van der Heide HJ, Koorevaar RC, Lemmens JA, van Kampen A, Schreurs BW.
    Arch Orthop Trauma Surg; 2007 Sep; 127(7):557-61. PubMed ID: 17106714
    [Abstract] [Full Text] [Related]

  • 19. No migration of acetabular cups after prophylaxis for heterotopic ossification.
    Ince A, Sauer U, Wollmerstedt N, Hendrich C.
    Clin Orthop Relat Res; 2007 Aug; 461():125-9. PubMed ID: 17415004
    [Abstract] [Full Text] [Related]

  • 20. Prevention of heterotopic ossification in cases of hypertrophic osteoarthritis submitted to total hip arthroplasty. Etidronate or Indomethacin?
    Vasileiadis GI, Sakellariou VI, Kelekis A, Galanos A, Soucacos PN, Papagelopoulos PJ, Babis GC.
    J Musculoskelet Neuronal Interact; 2010 Jun; 10(2):159-65. PubMed ID: 20516633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.